These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38849894)

  • 1. Novel insights into the potential applications of stem cells in pulmonary hypertension therapy.
    Guo S; Wang D
    Respir Res; 2024 Jun; 25(1):237. PubMed ID: 38849894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.
    Huang J; Lu W; Ouyang H; Chen Y; Zhang C; Luo X; Li M; Shu J; Zheng Q; Chen H; Chen J; Tang H; Sun D; Yuan JX; Yang K; Wang J
    Am J Respir Cell Mol Biol; 2020 Jan; 62(1):49-60. PubMed ID: 31211918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats.
    Takemiya K; Kai H; Yasukawa H; Tahara N; Kato S; Imaizumi T
    Basic Res Cardiol; 2010 May; 105(3):409-17. PubMed ID: 19838762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High shear stress-induced pulmonary hypertension alleviated by endothelial progenitor cells independent of autophagy.
    Xu BJ; Chen J; Chen X; Liu XW; Fang S; Shu Q; Hu L; Shi SS; Du LZ; Tan LH
    World J Pediatr; 2015 May; 11(2):171-6. PubMed ID: 25733212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol.
    Suen CM; Zhai A; Lalu MM; Welsh C; Levac BM; Fergusson D; McIntyre L; Stewart DJ
    Syst Rev; 2016 May; 5():89. PubMed ID: 27225668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alveolar epithelial cells are involved in pulmonary vascular remodeling and constriction of hypoxic pulmonary hypertension.
    Wang Y; Li X; Niu W; Chen J; Zhang B; Zhang X; Wang Y; Dang S; Li Z
    Respir Res; 2021 May; 22(1):134. PubMed ID: 33947399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension.
    Zhu Z; Fang Z; Hu X; Zhou S
    Rev Bras Cir Cardiovasc; 2015; 30(3):380-5. PubMed ID: 26313730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.
    Lee C; Mitsialis SA; Aslam M; Vitali SH; Vergadi E; Konstantinou G; Sdrimas K; Fernandez-Gonzalez A; Kourembanas S
    Circulation; 2012 Nov; 126(22):2601-11. PubMed ID: 23114789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR (CARSKNKDC) Peptide Modified ReNcell-Derived Extracellular Vesicles as a Novel Therapeutic Agent for Targeted Pulmonary Hypertension Therapy.
    Wang J; Hu L; Huang H; Yu Y; Wang J; Yu Y; Li K; Li Y; Tian T; Chen F
    Hypertension; 2020 Oct; 76(4):1147-1160. PubMed ID: 32829668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.
    Potter DR; Miyazawa BY; Gibb SL; Deng X; Togaratti PP; Croze RH; Srivastava AK; Trivedi A; Matthay M; Holcomb JB; Schreiber MA; Pati S
    J Trauma Acute Care Surg; 2018 Feb; 84(2):245-256. PubMed ID: 29251710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin improves pulmonary hypertension by promoting the homing and differentiation of bone marrow mesenchymal stem cells in lung tissue.
    Zhong Z; Li K; Shen C; Ma Y; Guo L
    Hum Cell; 2024 Jan; 37(1):214-228. PubMed ID: 37968533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies.
    Fukumitsu M; Suzuki K
    J Cardiol; 2019 Oct; 74(4):304-312. PubMed ID: 31109735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
    Veith C; Vartürk-Özcan I; Wujak M; Hadzic S; Wu CY; Knoepp F; Kraut S; Petrovic A; Gredic M; Pak O; Brosien M; Heimbrodt M; Wilhelm J; Weisel FC; Malkmus K; Schäfer K; Gall H; Tello K; Kosanovic D; Sydykov A; Sarybaev A; Günther A; Brandes RP; Seeger W; Grimminger F; Ghofrani HA; Schermuly RT; Kwapiszewska G; Sommer N; Weissmann N
    Circulation; 2022 Mar; 145(12):916-933. PubMed ID: 35175782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Sun F; Wang G; Pradhan A; Xu K; Gomez-Arroyo J; Zhang Y; Kalin GT; Deng Z; Vagnozzi RJ; He H; Dunn AW; Wang Y; York AJ; Hegde RS; Woods JC; Kalin TV; Molkentin JD; Kalinichenko VV
    Circulation; 2021 Aug; 144(7):539-555. PubMed ID: 34111939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.
    Kang H; Kim KH; Lim J; Kim YS; Heo J; Choi J; Jeong J; Kim Y; Kim SW; Oh YM; Choo MS; Son J; Kim SJ; Yoo HJ; Oh W; Choi SJ; Lee SW; Shin DM
    Stem Cells Dev; 2015 Jul; 24(14):1658-71. PubMed ID: 25761906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
    de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
    Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension.
    Suzuki T; Sato Y; Yamamoto H; Kato T; Kitase Y; Ueda K; Mimatsu H; Sugiyama Y; Onoda A; Saito S; Takahashi Y; Nakayama T; Hayakawa M
    Cytotherapy; 2020 Apr; 22(4):180-192. PubMed ID: 32139242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.
    Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Goldberg LR; Baird GL; Ventetuolo CE; Quesenberry PJ; Klinger JR
    Cardiovasc Res; 2016 Jun; 110(3):319-30. PubMed ID: 26980205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.